Alfred Scheidegger

Alfred Scheidegger is a seasoned leader in the biopharmaceutical industry, currently serving as Co-Founder and Chairman of the Board at Lipovectra Inc., where they focus on developing precision medicines for fat control. Previously, they held significant positions, including Chairman of the Board at The Genetics Company and multiple board roles at companies like TRACON Pharmaceuticals and Palyon Medical Corporation. With an extensive background in company formation and growth, Alfred has also contributed to various organizations, including Nextech Invest, where they were the Founder and Managing Partner. Alfred's academic credentials include advanced degrees in biochemistry and microbiology, complemented by business training from Harvard Business School.